Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse.

Pacey LK, Doss L, Cifelli C, van der Kooy D, Heximer SP, Hampson DR.

Mol Cell Neurosci. 2011 Mar;46(3):563-72. doi: 10.1016/j.mcn.2010.12.005. Epub 2011 Jan 6.

PMID:
21215802
2.

Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.

Higashimori H, Schin CS, Chiang MS, Morel L, Shoneye TA, Nelson DL, Yang Y.

J Neurosci. 2016 Jul 6;36(27):7079-94. doi: 10.1523/JNEUROSCI.1069-16.2016.

3.

Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.

Han K, Chen H, Gennarino VA, Richman R, Lu HC, Zoghbi HY.

Hum Mol Genet. 2015 Apr 1;24(7):1813-23. doi: 10.1093/hmg/ddu595. Epub 2014 Nov 28.

4.

Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures.

Pacey LK, Heximer SP, Hampson DR.

Mol Pharmacol. 2009 Jul;76(1):18-24. doi: 10.1124/mol.109.056127. Epub 2009 Apr 7.

5.

Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.

Guo W, Molinaro G, Collins KA, Hays SA, Paylor R, Worley PF, Szumlinski KK, Huber KM.

J Neurosci. 2016 Feb 17;36(7):2131-47. doi: 10.1523/JNEUROSCI.2921-15.2016.

6.

Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.

Thomas AM, Bui N, Graham D, Perkins JR, Yuva-Paylor LA, Paylor R.

Behav Brain Res. 2011 Oct 1;223(2):310-21. doi: 10.1016/j.bbr.2011.04.049. Epub 2011 May 6.

7.

Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome.

Dahlhaus R, El-Husseini A.

Behav Brain Res. 2010 Mar 17;208(1):96-105. doi: 10.1016/j.bbr.2009.11.019. Epub 2009 Nov 20.

PMID:
19932134
8.

Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.

Amiri A, Sanchez-Ortiz E, Cho W, Birnbaum SG, Xu J, McKay RM, Parada LF.

Autism Res. 2014 Feb;7(1):60-71. doi: 10.1002/aur.1342. Epub 2014 Jan 9.

PMID:
24408886
9.

Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).

Veeraragavan S, Graham D, Bui N, Yuva-Paylor LA, Wess J, Paylor R.

Behav Brain Res. 2012 Mar 1;228(1):1-8. doi: 10.1016/j.bbr.2011.11.018. Epub 2011 Nov 23.

11.

Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.

Gross C, Nakamoto M, Yao X, Chan CB, Yim SY, Ye K, Warren ST, Bassell GJ.

J Neurosci. 2010 Aug 11;30(32):10624-38. doi: 10.1523/JNEUROSCI.0402-10.2010.

12.

Correction of fragile X syndrome in mice.

Dölen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, Bear MF.

Neuron. 2007 Dec 20;56(6):955-62.

13.

Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.

Zhang L, Alger BE.

J Neurosci. 2010 Apr 21;30(16):5724-9. doi: 10.1523/JNEUROSCI.0795-10.2010.

14.

Synaptic vesicle dynamic changes in a model of fragile X.

Broek JAC, Lin Z, de Gruiter HM, van 't Spijker H, Haasdijk ED, Cox D, Ozcan S, van Cappellen GWA, Houtsmuller AB, Willemsen R, de Zeeuw CI, Bahn S.

Mol Autism. 2016 Mar 1;7:17. doi: 10.1186/s13229-016-0080-1. eCollection 2016.

15.

Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.

Spencer CM, Serysheva E, Yuva-Paylor LA, Oostra BA, Nelson DL, Paylor R.

Hum Mol Genet. 2006 Jun 15;15(12):1984-94. Epub 2006 May 4.

PMID:
16675531
16.

R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome.

Qin M, Huang T, Kader M, Krych L, Xia Z, Burlin T, Zeidler Z, Zhao T, Smith CB.

Int J Neuropsychopharmacol. 2015 Mar 28;18(9). pii: pyv034. doi: 10.1093/ijnp/pyv034.

17.

Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us.

Santos AR, Kanellopoulos AK, Bagni C.

Learn Mem. 2014 Sep 16;21(10):543-55. doi: 10.1101/lm.035956.114. Print 2014 Oct. Review.

18.

Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.

De Rubeis S, Fernández E, Buzzi A, Di Marino D, Bagni C.

Adv Exp Med Biol. 2012;970:517-51. doi: 10.1007/978-3-7091-0932-8_23. Review.

PMID:
22351071
19.

microRNAs and Fragile X Syndrome.

Lin SL.

Adv Exp Med Biol. 2015;888:107-21. doi: 10.1007/978-3-319-22671-2_7.

PMID:
26663181
20.

Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2.

Gross C, Yao X, Pong DL, Jeromin A, Bassell GJ.

J Neurosci. 2011 Apr 13;31(15):5693-8. doi: 10.1523/JNEUROSCI.6661-10.2011.

Supplemental Content

Support Center